Logo image
Targeting the homologous recombination pathway by small molecule modulators
Journal article   Open access   Peer reviewed

Targeting the homologous recombination pathway by small molecule modulators

Fei Huang and Alexander V Mazin
Bioorganic & medicinal chemistry letters, v 24(14), pp 3006-3013
15 Jul 2014
PMID: 24856061
url
https://doi.org/10.1016/j.bmcl.2014.04.088View
Published, Version of Record (VoR) Open

Abstract

Small Molecule Libraries - chemical synthesis Small Molecule Libraries - chemistry Small Molecule Libraries - pharmacology Animals Homologous Recombination - drug effects Humans
During the last decade, the use of small molecule (MW <500 Da) compounds that modulate (inhibit or activate) important proteins of different biological pathways became widespread. Recently, the homologous recombination (HR) pathway emerged as a target for such modulators. Development of small molecule modulators pursues two distinct but not mutually exclusive purposes: to create a research tool to study the activities or functions of proteins of interest and to produce drugs targeting specific pathologies. Here, we review the progress of small molecule development in the area of HR.

Metrics

9 Record Views
17 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Chemistry, Medicinal
Chemistry, Organic
Logo image